Glucose monitoring
Real-time continuous glucose monitoring (CGM) is advanced glucose monitoring technology that continuously measures interstitial glucose levels, displays the current blood glucose level as well as the direction and rate of change, and uses alarms and alerts to inform patients when blood glucose is exceeding or falling below specified thresholds.
Continuous glucose monitoring (CGM) was first reviewed by the HTA program in 2011.
- In 2017, the HCA director selected glucose monitoring for rereview based on newly available published evidence that could change the original coverage determination.
Status: Decision completed
Why is CGM being reviewed?
CGM was proposed for rereview based on new evidence and expanded indications for use.
Primary criteria ranking
- Safety = Medium
- Efficacy = High
- Cost = High
Documentation
| Type | Materials |
|---|---|
| Assessment (2018) | |
| Assessment (2011) |
Assessment timeline (2018)
- Draft key questions published: August 16, 2017
- Public comment period: August 16 to 29, 2017
- Final key questions published: September 14, 2017
- Draft report published: November 9, 2017
- Public comment period: November 9 to December 8, 2017
- Final report published: December 29, 2017
- HTCC public meeting: January 19, 2018